评估卢旺达COVID-19数据分析系统的采用和使用情况:一种混合方法方法
Hassan Mugabo1, Gilbert Rukundo1, Jean Claude S Ngabonziza1
1Research Innovation and Data Science, Rwanda Biomedical Center, Kigali, Rwanda (RBC), KG 644 St, Kigali, Kimihuruna, P.O. Box 7162, Kigali, Rwanda.
Oxford open digital health
|April 15, 2025
概括
卢旺达的COVID-19数据系统 (RCAS) 改善了数据链接和实时决策的访问. 用户对RCAS可持续性的支持与其可用性和对公共卫生数据管理的感知影响有关.
科学领域:
- 公共卫生信息学 公共卫生信息学
- 健康数据管理 管理健康数据
- 流行病学监测系统 流行病学监测系统
背景情况:
- 卢旺达展示了有效的COVID-19应对措施,但面临着碎片化数据系统的挑战.
- 有关数据链接,实时访问和公共卫生决策的完整性存在担忧.
研究的目的:
- 评估卢旺达COVID-19数据分析系统 (RCAS) 在公共卫生工作人员中的采用和影响.
- 评估RCAS在为政策和决策产生证据方面的作用.
主要方法:
- 采用混合方法的方法,包括对42名参与者进行在线问卷调查和对14名受访者进行关键信息人采访.
- 参与者从受过RCAS系统培训的人中选择,代表卢旺达生物医学中心,技术合作伙伴和卫生设施.
主要成果:
- 在关于RCAS的决策和对其可持续性的支持之间发现了显著的积极关系.
- 通过RCAS进行数据交换的轻松性显示出与长期可持续性的边际关联,这表明需要进一步调查.
结论:
- 在COVID-19之后,RCAS对数据链接,个人级数据访问和健康数据协调产生了积极的影响.
- 用户发现该系统可用,可接受和可互操作,支持其在改善卢旺达健康数据管理方面的作用.
相关概念视频
Steps in Outbreak Investigation
95
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
95
Statistical Methods for Analyzing Epidemiological Data
239
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
239
Statistical Analysis System (SAS)
79
SAS, short for Statistical Analysis System, is a powerful data analysis, management, and visualization tool. Developed by the SAS Institute in the early 1970s, SAS has evolved into a comprehensive software suite used across various industries for statistical analysis, business intelligence, and predictive modeling.
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
79
Statistical Software for Data Analysis and Clinical Trials
379
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
379
Introduction to R
208
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
208
Kaplan-Meier Approach
57
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
57


